Workflow
药物基因组学
icon
搜索文档
Myriad(MYGN) - 2025 Q1 - Earnings Call Transcript
2025-05-07 05:32
Myriad Genetics (MYGN) Q1 2025 Earnings Call May 06, 2025 04:30 PM ET Company Participants Matthew Scalo - SVP, Investor RelationsSam Raha - President & CEOMark Verratti - Chief Operating OfficerScott Leffler - Chief Financial OfficerDoug Schenkel - Managing DirectorPuneet Souda - Senior MDAndrew Cooper - VP - Equity ResearchTycho Peterson - Managing Director, Global EquitiesLu Li - Healthcare Equity Research, DirectorRicki Levitus - Equity Research Associate - Life Sciences Tools & Diagnostics Conference C ...